OliX Pharmaceuticals, Inc. — Investor Relations & Filings
OliX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company specializing in the development of therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric siRNA (asiRNA) platform to create treatments that selectively silence disease-causing genes. Its research and development efforts are focused on building a robust pipeline of drug candidates targeting a variety of illnesses with high unmet medical needs. The pipeline has a particular emphasis on ophthalmic and dermal disorders, with key programs addressing conditions such as hypertrophic scars, age-related macular degeneration (AMD), and other fibrotic and ocular diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2026-04-01 | Korean | |
| 정기주주총회결과 | 2026-03-26 | Korean | |
| 주식매수선택권부여에관한신고 | 2026-03-26 | Korean | |
| 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-26 | Korean | |
| 사업보고서 (2025.12) | 2026-03-18 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46363092 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 33129748 | 주식등의대량보유상황보고서(약식) | 2026-04-01 | Korean | ||
| 33046594 | 정기주주총회결과 | 2026-03-26 | Korean | ||
| 33046582 | 주식매수선택권부여에관한신고 | 2026-03-26 | Korean | ||
| 33046570 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-26 | Korean | ||
| 32970955 | 사업보고서 (2025.12) | 2026-03-18 | Korean | ||
| 32955397 | 감사보고서제출 | 2026-03-16 | Korean | ||
| 32928646 | [기재정정]의결권대리행사권유참고서류 | 2026-03-11 | Korean | ||
| 32927438 | 주주총회소집공고 | 2026-03-11 | Korean | ||
| 32927426 | 의결권대리행사권유참고서류 | 2026-03-11 | Korean | ||
| 32870279 | 주주총회소집결의 | 2026-03-03 | Korean | ||
| 32869880 | [기재정정]주식매수선택권부여에관한신고 | 2026-03-03 | Korean | ||
| 32869875 | [기재정정]주식매수선택권부여에관한신고 | 2026-03-03 | Korean | ||
| 32869872 | [기재정정]주식매수선택권부여에관한신고 | 2026-03-03 | Korean | ||
| 32840366 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-02-26 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
OliX Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16272/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16272 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16272 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16272 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16272}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OliX Pharmaceuticals, Inc. (id: 16272)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.